Safety and tolerability of obeticholic acid in chronic liver disease: a pooled analysis of 1878 individuals.
Ng CH, Tang ASP, Xiao J, Wong ZY, Yong JN, Fu CE, Zeng RW, Tan C, Wong GHZ, Teng M, Chee D, Tan DJH, Chan KE, Huang DQ, Chew NWS, Nah B, Siddqui MS, Sanyal AJ, Noureddin M, Muthiah M.
Ng CH, et al. Among authors: wong zy, wong ghz.
Hepatol Commun. 2023 Feb 9;7(3):e0005. doi: 10.1097/HC9.0000000000000005. eCollection 2023 Mar 1.
Hepatol Commun. 2023.
PMID: 36757421
Free PMC article.